Summary
We found that a receptor ligands differentially regulated the acetylcholine (ACh) neurotransmission in the rat brain. Acute administration of (+)-N-allylnormetazocine [(+)-SKF-10,047], a prototype σ1 receptor ligand, and 1,3-di(2-tolyl)guanidine (DTG), a non-specific σ receptor ligand, increased the extracellular ACh level in the rat hippocampus. This increase of hippocampal extracellular ACh level elicited by (+)-SKF-10,047 was more potent than that elicited by DTG. On the other hand, the striatal extracellular ACh level was slightly affected by (+)-SKF-10,047. In addition, DTG did not affect the striatal extracellular ACh level. Our previous studies have shown that both (+)-SKF-10,047 and DTG increased the extracellular ACh level in the rat frontal cortex. Taking all these data into consideration, the regulation of ACh neurotransmission by σ receptor ligands are different depending upon the brain region.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ajima A, Kato T (1988) Brain dialysis: detection of acetylcholine release in the striatum, hippocampus and frontal cortex of freely moving rats. Biogen Amines 5: 461–464
Ceci A, Smith M, French ED (1988) Activation of the A10 mesolimbic system by the σ-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic. Eur J Pharmacol 154: 53–57
Chesselet MF (1984) Presynaptic regulation of neurotransmitter release in the rat brain: facts and hypotheses. Neuroscience 12: 347–385
Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219: 1184–1189
Damsma G, Westerink BHC, de Vries JB, Van den Berg CJ, Horn AS (1987) Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis. J Neurochem 48: 1523–1528
Di Chiara G (1990)In-vivo brain dialysis of neurotransmitters. Trends Pharmacol Sci 11: 81–86
Earley B, Burke M, Leonard BE, Gouret CJ, Junien JL (1991) Evidence for an anti-amnesic effect of JO 1784 in the rat: a pontent and selective for the sigma receptor. Brain Res 546: 282–286
Ferris CD, Hirsch DJ, Brooks BP, Snyder SH (1991) σ Receptors: from molecule to man. J Neurochem 57: 729–737
Fujimori K, Yamamoto K (1987) Determination of acetylcholine and choline in perchlorate extracts of brain tissue using liquid chromatography-electrochemistry with an immobilized-enzyme reactor. J Chromatogr 414: 167–173
Gudelsky GA (1995) Effects of σ receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat. Eur J Pharmacol 286: 223–228
Gundlach AL, Largent BL, Synder SH (1986) Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J Neurosci 6: 1757–1770
Itzhak Y (1994) Multiple sigma binding sites in the brain. In: Itzhak Y (ed) Sigma receptors. Academic Press, London, pp 113–137
Junien JL, Roman FJ, Brunelle G, Pascaud X (1991) JO1784, a novel σ ligand, potentiates [3H]acetylcholine release from rat hippocampal slices. Eur J Pharmacol 200: 343–345
Kametani H, Kawamura H (1991) Circadian rhythm of cortical acetylcholine release as measured byIn vivo microdialysis in freely moving rats. Neurosci Lett 132: 263–266
Largent BL, Gundlach AL, Snyder SH (1986) Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]-SKF 10,047, (+)-[33H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J Pharmacol Exp Ther 238: 739–748
Matsuno K, Matsunaga K, Mita S (1992) Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis. Brain Res 575: 315–319
Matsuno K, Matsunaga K, Senda T, Mita S (1993a) Increase in extracellular acetylcholine level bysigma ligands in rat frontal cortex. J Pharmacol Exp Ther 265: 851–859
Matsuno K, Senda T, Matsunaga K, Mita S, Kaneto H (1993b) Similar ameliorating effects of benzomorphans and 5-HT2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors. Psychopharmacology 112: 134–141
Matsuno K, Senda T, Matsunaga K, Mita S (1994) Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system. Eur J Pharmacol 261: 43–51
Matsuno K, Senda T, Kobayashi T, Okamoto K, Nakata K, Mita S (1996) SA4503, a novel cognitive enhancer, with σ1 receptor agonistic properties. Behav Brain Res (in press)
Maurice T, Su TP, Parish DW, Nabeshima T, Privat A (1994) PRE-084, a σ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. Pharmacol Biochem Behav 49: 859–869
McCann DJ, Weissman AD, Su TP (1994)Sigma-1 andsigma-2 sites in rat brain: comparison of regional, ontogenetic, and subcellular patterns. Synapse 17: 182–189
Mesulam MM, Mufson EJ, Wainer BH, Levey AI (1983) Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Chl-Ch6). Neuroscience 10: 1185–1201
Patrick SL, Walker JM, Perkel JM, Lockwood M, Patrick RL (1993) Increases in rat striatal extracellular dopamine and vacuous chewing produced by two a receptor ligands. Eur J Pharmacol 231: 243–249
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW, Taylor DP (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 13: 85–86
Riekkinen Jr P, Sirvio J, Riekkinen M, Riekkinen P (1991) Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats. Pharmacol Biochem Bahav 39: 841–846
Siniscalchi A, Cristofori P, Veratti E (1987) Influence of N-allyl-normetazocine on acetylcholine release from brain slices: involvement of muscarinic receptors. Naunyn Schmiedebergs Arch Pharmacol 336: 425–429
Sircar R, Nichtenhauser R, Leni JR, Zukin SR (1986) Characterization and autoradio-graphic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/“Sigma opiate” receptor commonality. J Pharmacol Exp Ther 237: 681–688
Su TP (1991) σ Receptors, putative links between nervous, endocrine, and immune systems. Eur J Biochem 200: 633–642
Sutherland RJ, McDonald RJ (1990) Hippocampus, amygdala, and memory deficits in rats. Behav Brain Res 37: 57–59
Toide K, Arima T (1989) Effects of cholinergic drugs on extracellular levels of acetylcholine and choline in rat cortex, hippocampus and striatum studied by brain dialysis. Eur J Pharmacol 173: 133–141
Ungerstedt U (1984) Measurement of neurotransmitter release by intracranial dialysis. In: Marsden CA (ed) Measurement of neurotransmitter release in vivo. Wiley, Chichester, pp 81–105
Ungerstedt U, Forster Ch, Herrera-Marschitz M, Hoffman I, Jungnelius U, Tossman U, Zetterström T (1982) Brain dialysis-a new in vivo technique for studying neurotransmitter release and metabolism. Neurosci Lett 10 [Suppl]: 493
Volonté M, Ceci A, Borsini F (1992) Effect of haloperidol and clozapine on (+)-SKF-10,047-induced dopamine release: role of 5-HT3 receptors. Eur J Pharmacol 213: 163–164
Walker JM, Bowen WD, Walker FO, Matsumoto RR, de Costa B, Rice KC (1990) Sigma receptors: biology and function. Pharmacol Rev 42: 355–402
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kobayashi, T., Matsuno, K. & Mita, S. Regional differences of the effect of σ receptor ligands on the acetylcholine release in the rat brain. J. Neural Transmission 103, 661–669 (1996). https://doi.org/10.1007/BF01271226
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01271226